Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 62.1 TWD 0.16% Market Closed
Market Cap: 10.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-8.5
Current
-7.9
Median
6.2
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-8.5
=
Enterprise Value
10.9B TWD
/
Operating Cash Flow
-1.3B TWD
All Countries
Close
Market Cap EV/OCF
KY
Tanvex BioPharma Inc
TWSE:6541
10.2B TWD -8.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 093.3
US
Abbvie Inc
NYSE:ABBV
314.6B USD 22.2
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 26
US
Gilead Sciences Inc
NASDAQ:GILD
117.3B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.4B USD -115.9
US
Epizyme Inc
F:EPE
94.1B EUR -470.9
AU
CSL Ltd
ASX:CSL
136.4B AUD 34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -73.7
NL
argenx SE
XBRU:ARGX
36.2B EUR -133.5
 
KY
Tanvex BioPharma Inc
TWSE:6541
Average EV/OCF: 22.1
Negative Multiple: -8.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 093.3
US
Abbvie Inc
NYSE:ABBV
22.2
US
Amgen Inc
NASDAQ:AMGN
26
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.9
AU
CSL Ltd
ASX:CSL
34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133.5

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More